secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2022-06-27T23:59:59+00:00
Accession:  0001493152-22-017864
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncotelic issues $335K convertible note to Blue Lake Partners as part of $1M financing
--------------------------------------------------------------------------------

- Issued $335,000 convertible promissory note to Blue Lake Partners, LLC at 12% interest.
- Note matures in one year; convertible into common stock at $0.10 per share.
- Issued 3,025,000 warrants to purchase common stock at $0.20 per share.
- Financing part of cumulative $1M raise via JH Darbie; $605K from Mast Hill in May 2022.
- Proceeds for general working capital; not for insider loans or illegal purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000149315222017864/0001493152-22-017864-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000149315222017864/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-017864

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer